NK and NK/T cells in human senescence

Vaccine

Volumn 18, Issue 16, 2000, Pages 1613-1620

  Solana, Rafael ^a   Mariani, Erminia ^b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Cytotoxicity; Immunosenescence; NK cells

Indexed keywords

CD69 ANTIGEN; CHEMOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; PERFORIN; TUMOR NECROSIS FACTOR ALPHA;

AGING; CELL MATURATION; CELL MEDIATED CYTOTOXICITY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNOREGULATION; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SENESCENCE; TH1 CELL;

EID: 0033951533     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00495-8     Document Type: Article

References (81)

1. Trinchieri G. Immunobiology of interleukin-12. Immunol. Res. 17:1998;269-278.
2. Carlyle J.R., Zuniga-Pflucker J.C. Lineage commitment and differentiation of T and natural killer lymphocytes in the fetal mouse. Immunol. Rev. 165:1998;63-74.
3. Raulet D.H. Development and tolerance of natural killer cells. Curr. Opin. Immunol. 11:1999;129-134.
4. Carson W.E., Fehniger T.A., Haldar S., Eckhert K., Lindemann M.J., Lai C.F., Croce C.M., Baumann H., Caligiuri M.A. A potential role for interleukin-15 in the regulation of human natural killer cell survival. J. Clin. Invest. 99:1997;937-943.
5. Yu H., Fehniger T.A., Fuchshuber P., Thiel K.S., Vivier E., Carson W.E., Caligiuri M.A. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15. Blood. 92:1998;3647-3657.
6. Trinchieri G., Solana R., Pena J. MHC antigens and NK cells. 1, Definition and biology of natural killer cells. 1994;1-15 Landes, Austin, TX.
7. Lanier L.L. NK cell receptors. Annu. Rev. Immunol. 16:1998;359-393.
8. Nakazawa T., Agematsu K., Yabuhara A. Later development of Fas ligand-mediated cytotoxicity as compared with granule-mediated cytotoxicity during the maturation of natural killer cells. Immunology. 92:1997;180-187.
9. Lopez-Botet M., Perez-Villar J.J., Carretero M., Rodriguez A., Melero I., Bellon T., Llano M., Navarro F. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules. Immunol. Rev. 155:1997;165-174.
10. Moretta A., Bottino C., Vitale M., Pende D., Biassoni R., Mingari M.C., Moretta L. Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 14:1996;619-648.
11. Lanier L.L., Yu G., Phillips J.H. Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells. Nature. 342:1989;803-805.
12. Vivier E., Morin P.M., O'Brien C., Schlossman S.F., Anderson P. CD2 is functionally linked to the zeta-natural killer receptor complex. Eur. J. Immunol. 21:1991;1077-1080.
13. Sivori S., Vitale M., Morelli L., Sanseverino L., Augugliaro R., Bottino C., Moretta L., Moretta A. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J. Exp. Med. 186:1997;1129-1136.
14. Lanier L.L., Corliss B.C., Wu J., Leong C., Phillips J.H. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature. 391:1998;703-707.
15. Lanier L.L., Corliss B., Wu J., Phillips J.H. Association of DAP12 with Activating CD94/NKG2C NK Cell Receptors. Immunity. 8:1998;693-701.
16. Vitale M., Bottino C., Sivori S., Sanseverino L., Castriconi R., Marcenaro E., Augugliaro R., Moretta L., Moretta A. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187:1998;2065-2072.
17. Moretta A., Poggi A., Pende D., Tripodi G., Orengo A.M., Pella N., Augugliaro R., Bottino C., Ciccone E., Moretta L. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta. J. Exp. Med. 174:1991;1393-1398.
18. Borrego F., Robertson M.J., Ritz J., Pena J., Solana R. CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor. Immunology. 97:1999;159-166.
19. Lanier L.L., Chang C., Phillips J.H. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J. Immunol. 153:1994;2417-2428.
20. Binstadt B.A., Brumbaugh K.M., Dick C.J., Scharenberg A.M., Williams B.L., Colonna M., Lanier L.L., Kinet J.P., Abraham R.T., Leibson P.J. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity. 5:1996;629-638.
21. Burshtyn D.N., Scharenberg A.M., Wagtmann N., Rajagopalan S., Berrada K., Yi T., Kinet J.P., Long E.O. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity. 4:1996;77-85.
22. Binstadt B.A., Brumbaugh K.M., Leibson P.J. Signal transduction by human NK cell MHC-recognizing receptors. Immunol. Rev. 155:1997;197-203.
23. Luque I., Solana R., Galiani M.D., Gonzalez R., Garcia F., Lopez de Costa J.A., Pena J. Threonine 80 on HLA-B27 confers protection against lysis by a group of natural killer clones. Eur. J. Immunol. 26:1996;1974-1977.
24. Moretta A., Biassoni R., Bottino C., Pende D., Vitale M., Poggi A., Mingari M.C., Moretta L. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol. Rev. 155:1997;105-117.
25. Borrego F., Ulbrecht M., Weiss E.H., Coligan J.E., Brooks A.G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187:1998;813-818.
26. Braud V.M., Allan D.S., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:1998;795-799.
27. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., Geraghty D.E. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA. 95:1998;5199-5204.
28. Carson W.E., Giri J.G., Lindemann M.J., Linett M.L., Ahdieh M., Paxton R., Anderson D., Eisenmann J., Grabstein K., Caligiuri M.A. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1994;1395-1403.
29. Flamand L., Stefanescu I., Menezes J. Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J. Clin. Invest. 97:1996;1373-1381.
30. Trinchieri G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70:1998;83-243.
31. Fehniger T.A., Shah M.H., Turner M.J., Vandeusen J.B., Whitman S.P., Cooper M.A., Suzuki K., Wechser M., Goodsaid F., Caligiuri M.A. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J. Immunol. 162:1999;4511-4520.
32. Hyodo Y., Matsui K., Hayashi N., Tsutsui H., Kashiwamura S., Yamauchi H., Hiroishi K., Takeda K., Tagawa Y., Iwakura Y., et al. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J. Immunol. 162:1999;1662-1668.
33. Kim C.H., Pelus L.M., Appelbaum E., Johanson K., Anzai N., Broxmeyer H.E. CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors. Cell Immunol. 193:1999;226-235.
34. Maghazachi A.A., al-Aoukaty A. Chemokines activate natural killer cells through heterotrimeric G-proteins: implications for the treatment of AIDS and cancer. FASEB J. 12:1998;913-924.
35. Monteiro J.M., Harvey C., Trinchieri G. Role of interleukin-12 in primary influenza virus infection. J. Virol. 72:1998;4825-4831.
36. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defence: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:1998;189-220.
37. Biron C.A. Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. Semin. Immunol. 10:1998;383-390.
38. Ogata K., Yokose N., Tamura H., An E., Nakamura K., Dan K., Nomura T. Natural killer cells in the late decades of human life. Clin. Immunol. Immunopathol. 84:1997;269-275.
39. Heller D.A., Ahern F.M., Stout J.T., McClearn G.E. Mortality and biomarkers of aging in heterogeneous stock (HS) mice. J. Gerontol. Ser. A Biol. Sci. Med. 53:1998;B217-B230.
40. Remarque E., Pawelec P. T cell immunosenescence and its clinical relevance in man. Rev. Clin. Gerontol. 8:1998;5-14.
41. Sansoni P., Cossarizza A., Brianti V., Fagnoni F., Snelli G., Monti D., Marcato A., Passeri G., Ortolani C., Forti E., et al. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood. 82:1993;2767-2773.
42. Cossarizza A., Ortolani C., Monti D., Franceschi C. Cytometric analysis of immunosenescence. Cytometry. 27:1997;297-313.
43. Franceschi C., Monti D., Sansoni P., Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol. Today. 16:1995;12-16.
44. Mariani E., Ravaglia G., Forti P., Meneghetti A., Tarozzi A., Maioli F., Boschi F., Pratelli L., Pizzoferrato A., Piras F., et al. Vitamin D, thyroid hormones and muscle mass influence natural killer (NK) innate immunity in healthy nonagenarians and centenarians. Clin. Exp. Immunol. 116:1999;19-27.
45. Ravaglia G, Forti P, Maioli F, Bastagli L, Facchini A, Mariani E, Savarino L, Sassi S, Cucinota D, Lenaz G, Micronutrient status and natural killer cell function in healthy free-living subjects aged 90 years and over, J. Am. Clin. Nutr. 1999;34:435-443.
46. Pawelec G., Solana R. Immunosenescence. Immunol. Today. 18:1997;514-516.
47. Pawelec G., Solana R., Remarque E., Mariani E. Impact of aging on innate immunity. J. Leukoc. Biol. 64:1998;703-712.
48. Solana R., Pawelec G. Molecular and cellular basis of immunosenescence. Mech. Ageing Dev. 102:1998;115-129.
49. Pawelec G., Effros R.B., Caruso C., Remarque E., Barnett Y., Solana R. T cells and aging (update February 1999). Front Biosci. 4:1999;D216-D269.
50. Solana R, Alonso MC, Pena J, Natural killer cells in healthy ageing, Exp. Gerontol. 1999; 34:435-43.
51. Facchini A., Mariani E., Mariani A.R., Papa S., Vitale M., Manzoli F.A. Increased number of circulating Leu 11+ (CD 16) large granular lymphocytes and decreased NK activity during human ageing. Clin. Exp. Immunol. 68:1987;340-347.
52. Vitale M., Zamai L., Neri L.M., Galanzi A., Facchini A., Rana R., Cataldi A., Papa S. The impairment of natural killer function in the healthy aged is due to a postbinding deficient mechanism. Cell Immunol. 145:1992;1-10.
53. Borrego F., Alonso C., Galiani M., Carracedo J., Ramirez R., Ostos B., Pena J., Solana R. NK phenotypic markers and IL2 response in NK cells from elderly people. Exp. Gerontol. 34:1999;253-265.
54. Baume D.M., Robertson M.J., Levine H., Manley T.J., Schow P.W., Ritz J. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells. Eur. J. Immunol. 22:1992;1-6.
55. Krishnaraj R., Svanborg A. Preferential accumulation of mature NK cells during human immunosenescence. J. Cell Biochem. 50:1992;386-391.
56. Mariani E., Monaco M.C., Cattini L., Sinoppi M., Facchini A. Distribution and lytic activity of NK cell subsets in the elderly. Mech. Ageing Dev. 76:1994;177-187.
57. Kutza J., Murasko D.M. Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha. Cell Immunol. 155:1994;195-204.
58. Kutza J., Murasko D.M. Age-associated decline in IL-2 and IL-12 induction of LAK cell activity of human PBMC samples. Mech. Ageing Dev. 90:1996;209-222.
59. Mariani E., Roda P., Mariani A.R., Vitale M., Degrassi A., Papa S., Facchini A. Age-associated changes in CD8+ and CD16+ cell reactivity: clonal analysis. Clin. Exp. Immunol. 81:1990;479-484.
60. Mariani E., Sgobbi S., Meneghetti A., Tadolini M., Tarozzi A., Sinoppi M., Cattini L., Facchini A. Perforins in human cytolytic cells: the effect of age. Mech. Ageing Dev. 92:1996;195-209.
61. Mariani E., Mariani A.R., Meneghetti A., Tarozzi A., Cocco L., Facchini A. Age-dependent decreases of NK cell phosphoinisitide turnover during spontaneous but not Fc mediated cytotlytic activity. Int. Immunol. 10:1998;981-989.
62. Fernandes G., Gupta S. Natural killing and antibody-dependent cytotoxicity by lymphocyte subpopulations in young and aging humans. J. Clin. Immunol. 1:1981;141-148.
63. Edwards D.L., Avis F.P. Antibody-dependent cellular cytotoxicity effector cell capability among normal individuals. J. Immunol. 123:1979;1887-1893.
64. Krishnaraj R. Immunosenescence of human NK cells: effects on tumor target recognition, lethal hit and interferon sensitivity. Immunol. Lett. 34:1992;79-84.
65. Krishnaraj R. Senescence and cytokines modulate the NK cell expression. Mech. Ageing Dev. 96:1997;89-101.
66. Rink L., Cakman I., Kirchner H. Altered cytokine production in the elderly. Mech. Ageing Dev. 102:1998;199-210.
67. Krishnaraj R., Bhooma T. Cytokine sensitivity of human NK cells during immunosenescence. 2. IL2-induced interferon gamma secretion. Immunol. Lett. 50:1996;59-63.
68. Krishnaraj R. Senescence and cytokines modulate the NK cell expression. Mech. Ageing Dev. 96:1997;89-101.
69. Rukavina D., Laskarin G., Rubesa G., Strbo N., Bedenicki I., Manestar D., Glavas M., Christmas S.E., Podack E.R. Age-related decline of perforin expression in human cytotoxic T lymphocytes and natural killer cells. Blood. 92:1998;2410-2420.
70. Arase N., Arase H., Park S.Y., Ohno H., Ra C., Saito T. Association with FcRgamma is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1.1+ T cells. J. Exp. Med. 186:1997;1957-1963.
71. Cui J., Shin T., Kawano T., Sato H., Kondo E., Toura I., Kaneko Y., Koseki H., Kanno M., Taniguchi M. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science. 278:1997;1623-1626.
72. Koyasu S. CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells. J. Exp. Med. 179:1994;1957-1972.
73. Tamada K., Harada M., Abe K., Li T., Tada H., Onoe Y., Nomoto K. Immunosuppressive activity of cloned natural killer (NK1.1+) T cells established from murine tumor-infiltrating lymphocytes. J. Immunol. 158:1997;4846-4854.
74. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., et al. CD1 d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science. 278:1997;1626-1629.
75. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Sato H., Kondo E., Harada M., Koseki H., Nakayama T., et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc. Natl. Acad. Sci. USA. 95:1998;5690-5693.
76. Makino M., Winkler D.F., Wunderlich J., Hartley J.W., Morse H.C., Holmes K.L. High expression of NK-1.1 antigen is induced by infection with murine AIDS virus. Immunology. 80:1993;319-325.
77. Poynter M.E., Mu H.H., Chen X.P., Daynes R.A. Activation of NK1.1+ T cells in vitro and their possible role in age-associated changes in inducible IL-4 production. Cell Immunol. 179:1997;22-29.
78. Tsukahara A., Seki S., Iiai T., Moroda T., Watanabe H., Suzuki S., Tada T., Hiraide H., Hatakeyama K., Abo T. Mouse liver T cells: their change with aging and in comparison with peripheral T cells. Hepatology. 26:1997;301-309.
79. Okada T., Iiai T., Kawachi Y., Moroda T., Takii Y., Hatakeyama K., Abo T. Origin of CD57+ T cells which increase at tumour sites in patients with colorectal cancer. Clin. Exp. Immunol. 102:1995;159-166.
80. McNerlan S.E., Rea I.M., Alexander H.D., Morris T.C. Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging. J. Clin. Immunol. 18:1998;31-38.
81. Miyaji C., Watanabe H., Minagawa M., Toma H., Kawamura T., Nohara Y., Nozaki H., Sato Y., Abo T. Numerical and functional characteristics of lymphocyte subsets in centenarians. J. Clin. Immunol. 17:1997;420-429.